A carregar...
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal tissues. The α-emitting radionuclide bismuth-213 ((...
Na minha lista:
| Publicado no: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8143329/ https://ncbi.nlm.nih.gov/pubmed/33919391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050599 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|